34
Participants
Start Date
April 30, 2004
Primary Completion Date
February 28, 2006
Study Completion Date
August 31, 2006
Bronchial Thermoplasty with the Alair System
Alair treatment plus standard-of-care therapy of high dose inhaled corticosteroids and long acting beta-agonists with or without oral corticosteroids at a dose of ≤ 30 mg/day.
Control
Standard-of-care therapy of high dose inhaled corticosteroids and long acting beta-agonists with or without oral corticosteroids at a dose of ≤30 mg/day.
Lead Sponsor
Boston Scientific Corporation
INDUSTRY